Squarepoint’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-47,884
| Closed | -$724K | – | 3756 |
|
|
2022
Q3 | $724K | Sell |
47,884
-16,035
| -25% | -$186K | ﹤0.01% | 1977 |
|
|
2022
Q2 | $479K | Buy |
63,919
+49,400
| +340% | +$348K | ﹤0.01% | 2034 |
|
|
2022
Q1 | $132K | Sell |
14,519
-65,188
| -82% | -$502K | ﹤0.01% | 2563 |
|
|
2021
Q4 | $560K | Buy |
79,707
+62,732
| +370% | +$656K | ﹤0.01% | 2068 |
|
|
2021
Q3 | $194K | Sell |
16,975
-30,212
| -64% | -$442K | ﹤0.01% | 2502 |
|
|
2021
Q2 | $755K | Buy |
+47,187
| New | +$809K | ﹤0.01% | 1838 |
|
|
2021
Q1 | – | Sell |
-51,417
| Closed | -$695K | – | 3798 |
|
|
2020
Q4 | $695K | Buy |
51,417
+16,260
| +46% | +$196K | 0.01% | 1573 |
|
|
2020
Q3 | $414K | Buy |
35,157
+16,340
| +87% | +$199K | 0.01% | 1572 |
|
|
2020
Q2 | $278K | Buy |
18,817
+1,751
| +10% | +$25.9K | ﹤0.01% | 1645 |
|
|
2020
Q1 | $230K | Sell |
17,066
-64,339
| -79% | -$1.22M | 0.01% | 1411 |
|
|
2019
Q4 | $1.97M | Sell |
81,405
-84,466
| -51% | -$1.75M | 0.01% | 914 |
|
|
2019
Q3 | $3.19M | Buy |
165,871
+135,716
| +450% | +$3.11M | 0.03% | 636 |
|
|
2019
Q2 | $891K | Sell |
30,155
-59,894
| -67% | -$2.31M | 0.01% | 1327 |
|
|
2019
Q1 | $4.28M | Buy |
90,049
+79,372
| +743% | +$3.49M | 0.05% | 497 |
|
|
2018
Q4 | $385K | Sell |
10,677
-17,263
| -62% | -$810K | ﹤0.01% | 1388 |
|
|
2018
Q3 | $1.72M | Buy |
+27,940
| New | +$1.8M | 0.02% | 776 |
|
|
2018
Q2 | – | Sell |
-10,502
| Closed | -$570K | – | 2150 |
|
|
2018
Q1 | $570K | Buy |
+10,502
| New | +$587K | 0.01% | 1041 |
|
|
2017
Q3 | – | Sell |
-11,700
| Closed | -$615K | – | 1967 |
|
|
2017
Q2 | $615K | Sell |
11,700
-1,134
| -9% | -$52.8K | 0.01% | 885 |
|
|
2017
Q1 | $582K | Sell |
12,834
-16,310
| -56% | -$727K | 0.02% | 800 |
|
|
2016
Q4 | $1.1M | Buy |
29,144
+14,101
| +94% | +$533K | 0.05% | 470 |
|
|
2016
Q3 | $568K | Buy |
+15,043
| New | +$332K | 0.04% | 517 |
|
Squarepoint's AERI Position: Q4 2022 in Review
Squarepoint sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 47,884 shares — an estimated $724K sold.
Squarepoint first reported a position in AERI in Q3 2016 and held it in 21 quarters. The position peaked at $4.28M in Q1 2019. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- Squarepoint reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Squarepoint sold 47,884 Aerie Pharmaceuticals shares in Q4 2022, an estimated $724K.
- Squarepoint first reported a position in Aerie Pharmaceuticals in Q3 2016 and held it in 21 quarters.
- Squarepoint's Aerie Pharmaceuticals position peaked at $4.28M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on Squarepoint's 13F filing for Q4 2022, filed 14 Feb 2023.